Therefore, to investigate whether SNPs of the VEGF gene will influence the responsiveness to chemotherapy of patients with CRC through a combination of anti-angiogenic agents, a subgroup analysis was performed subsequently of a combination of anti-angiogenic agents in chemotherapy strategies. This evidence concerns the gene VEGFA and colorectal carcinoma.